- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Botulinum toxin A injection may ease pain due to osteoarthritis of base-of-thumb: Lancet
France: The phase 3 RHIBOT trial found that Botulinum toxin A is effective in relieving pain and can be considered as a fast-acting, intra-articular therapy in individuals having osteoarthritis of base-of-thumb. The article was published in The Lancet Rheumatology.
Globally, millions of people suffer from Osteoarthritis, the most common form of arthritis. It occurs when flexible tissue at the ends of bones wears down. Osteoarthritis at the base of the thumb is a common and highly disabling condition that severely compromises the function of the entire hand. Botulinum toxins are neurotoxins that affect nerves. Botulinum toxin is a proven and widely used treatment for numerous conditions characterized by excessive muscular contractions. Recent studies have assessed the analgesic effect of botulinum toxin in joint pain. Intra-articular botulinum toxin A injection might have analgesic effects in patients with joint diseases.
Christelle Nguyen, Université Paris Cité, France and colleagues conducted a double-blind, randomised, controlled, phase 3 trial to compare the effects of intra-articular botulinum toxin A injection with those of intra-articular saline injection for patients with painful base-of-thumb osteoarthritis.
The research team recruited 60 adult patients with x-ray evidence of trapeziometacarpal osteoarthritis, who reported a pain intensity score of at least 30 on an 11-point numeric rating scale (0: no pain to 100: maximal pain). Participants were randomly assigned (1:1), to receive an ultrasound-guided injection of either botulinum toxin A (50 Allergan units) in 1 mL of saline (experimental group, n-30) or 1 mL of saline alone (control group,n-30) in the trapeziometacarpal joint, in addition to custom-made rigid splinting. The primary outcome was the mean change from baseline in base-of-thumb pain on a numeric rating scale at 3 months after injection, analysed by intention to treat.
Key findings of the study,
• Base-of-thumb pain score was 60•0 of 100•0, at baseline,
• At 3 months, the mean reduction in base-of-thumb pain was –25•7 in the experimental and control groups.
• Overall, 53% of the participants in the experimental group and 47% of participants in the control group reported adverse events.
• During follow-up, 47% of the participants in the experimental group and 7% of participants in the control group reported a mild transient motor deficit of the thenar muscle.
• No serious adverse events were reported.
The authors conclude that Botulinum toxin A could be considered a fast-acting, intra-articular therapy targeting chronic pain in individuals with base-of-thumb osteoarthritis. Future studies are needed to investigate the potential mechanism of the effects observed in this trial, to replicate the findings.
The effects of repeated injections of Botulinum toxin A in the long run and their clinical effectiveness, including an analysis of cost-effectiveness should be assessed, the authors wrote.
Reference:
Prof Christelle Nguyen, Hendy Abdoul, Raphaël Campagna, , Henri Guerini, , Léa Jilet, Catherine Bedin, et al. Published:July, 2022. DOI: https://doi.org/10.1016/S2665-9913(22)00129-1
BDS
Dr. Hiral patel (BDS) has completed BDS from Gujarat University, Baroda. She has worked in private dental steup for 8years and is currently a consulting general dentist in mumbai. She has recently completed her advanced PG diploma in clinical research and pharmacovigilance. She is passionate about writing and loves to read, analyses and write informative medical content for readers. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751